How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection

Name: How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
Uploaded: 2024-01-26T19:17:06+00:00
Duration: 3 min 13 s
Description: Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Pediatric Hidradenitis Suppurativa
Pediatric Hidradenitis Suppurativa
Rare Disease
Pediatric Hidradenitis Suppurativa
Tyler Sy; Emily S. Gorell, DO, MS
Tyler Sy; Emily S. Gorell, DO, MS
Tips and Tricks for Prescribing Biologics for Pediatric Patients
Tips and Tricks for Prescribing Biologics for Pediatric Patients
Maui Derm Hawaii 2026
Tips and Tricks for Prescribing Biologics for Pediatric Patients
An Overview of Topical Therapies for Managing Pediatric AD
An Overview of Topical Therapies for Managing Pediatric AD
Atopic Dermatitis
An Overview of Topical Therapies for Managing Pediatric AD
Savannah Bush; Lena Chu, MD
Savannah Bush; Lena Chu, MD
The Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
The Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
Rare Disease
The Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
Colleen Cotton, MD
Colleen Cotton, MD

VIDEOS

PODCASTS

COLUMNS

NEWS

CONFERENCE COVERAGE

DERMATOLOGY HUB

How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection

Recommended

How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection

Recommended

Title